US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.530
  • -0.040-2.55%
Close Aug 30 16:00 ET
  • 1.530
  • 0.0000.00%
Post 16:00 ET
11.80MMarket Cap-850P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
(Q1)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
12.64%-1.08M
Net income from continuing operations
107.73%333.76K
1,165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
-1.81%-4.32M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
Operating gains losses
---4.17M
---2.62M
---230K
---3.31M
--1.98M
----
----
----
----
----
Other non cash items
-212.05%-195K
----
----
----
40,007.11%913.64K
399.40%174.02K
91.21%5.88K
6,692.30%165.87K
--0
-90.80%2.28K
Change In working capital
200.58%298.89K
151.90%87.15K
123.67%135.74K
-7,954.17%-554.61K
39.82%630.62K
-3,387.23%-297.17K
-175.60%-167.93K
-215.94%-573.37K
98.41%-6.89K
263.55%451.01K
-Change in prepaid assets
-1,026.06%-152.12K
-48.23%37.96K
-66.46%25.43K
-2.57%-234.54K
-71.18%19.03K
35.80%-13.51K
-8.26%73.33K
11.97%75.8K
-392.17%-228.66K
126.74%66.02K
-Change in payables and accrued expense
259.00%451.01K
120.39%49.19K
116.99%110.31K
-244.32%-320.07K
58.86%611.59K
-1,033.17%-283.66K
-269.66%-241.25K
-252.08%-649.17K
143.50%221.78K
1,435.05%384.99K
Cash from discontinued investing activities
Operating cash flow
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
12.64%-1.08M
Investing cash flow
Cash flow from continuing investing activities
-5M
0
0
0
Net investment purchase and sale
---5M
--0
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---5M
--0
---5M
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
-3.78M
-103.87%-3.39M
-2.09M
Net common stock issuance
-107.94%-28.2M
72.73%-1.17M
89.39%-400.71K
95.13%-164.95K
-1,165.39%-26.46M
-115.52%-13.56M
-113.60%-4.31M
---3.78M
-106.08%-3.39M
---2.09M
Net preferred stock issuance
--17.49M
---9.52M
---6.64M
---1.35M
--35M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-92.05%70
--0
--0
--0
-92.05%70
--880
--0
--0
--0
--880
Net other financing activities
----
----
----
----
---2.26M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
---3.78M
-103.87%-3.39M
---2.09M
Net cash flow
Beginning cash position
-20.33%68.04M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
3,778.14%85.4M
-16.16%72.64M
-11.47%76.96M
8,471.89%82.23M
3,778.14%85.4M
Current changes in cash
-2.92%-17.86M
-140.04%-11.03M
-182.79%-12.22M
76.53%-1.24M
308.61%6.62M
-120.86%-17.35M
-269.78%-4.6M
-1,346.47%-4.32M
-106.12%-5.26M
-155.74%-3.17M
Effect of exchange rate changes
92.99%-508
91.70%-438
141.90%1.07K
-120.97%-1.59K
-65.41%451
-256.67%-7.25K
-248.87%-5.28K
-1,116.19%-2.55K
-124.78%-720
180.74%1.3K
End cash Position
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
-16.16%72.64M
-11.47%76.96M
8,471.89%82.23M
Free cash flow
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
12.64%-1.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023(Q2)Oct 31, 2022(Q1)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M12.64%-1.08M
Net income from continuing operations 107.73%333.76K1,165.95%1.35M18.92%-619.54K248.36%2.79M-106.04%-3.18M-1.81%-4.32M91.12%-126.34K5.81%-764.14K-91.94%-1.88M-50.67%-1.55M
Operating gains losses ---4.17M---2.62M---230K---3.31M--1.98M--------------------
Other non cash items -212.05%-195K------------40,007.11%913.64K399.40%174.02K91.21%5.88K6,692.30%165.87K--0-90.80%2.28K
Change In working capital 200.58%298.89K151.90%87.15K123.67%135.74K-7,954.17%-554.61K39.82%630.62K-3,387.23%-297.17K-175.60%-167.93K-215.94%-573.37K98.41%-6.89K263.55%451.01K
-Change in prepaid assets -1,026.06%-152.12K-48.23%37.96K-66.46%25.43K-2.57%-234.54K-71.18%19.03K35.80%-13.51K-8.26%73.33K11.97%75.8K-392.17%-228.66K126.74%66.02K
-Change in payables and accrued expense 259.00%451.01K120.39%49.19K116.99%110.31K-244.32%-320.07K58.86%611.59K-1,033.17%-283.66K-269.66%-241.25K-252.08%-649.17K143.50%221.78K1,435.05%384.99K
Cash from discontinued investing activities
Operating cash flow 43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M12.64%-1.08M
Investing cash flow
Cash flow from continuing investing activities -5M000
Net investment purchase and sale ---5M--0--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---5M--0---5M--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M-3.78M-103.87%-3.39M-2.09M
Net common stock issuance -107.94%-28.2M72.73%-1.17M89.39%-400.71K95.13%-164.95K-1,165.39%-26.46M-115.52%-13.56M-113.60%-4.31M---3.78M-106.08%-3.39M---2.09M
Net preferred stock issuance --17.49M---9.52M---6.64M---1.35M--35M--0--0--0--0--0
Proceeds from stock option exercised by employees -92.05%70--0--0--0-92.05%70--880--0--0--0--880
Net other financing activities -------------------2.26M--------------------
Cash from discontinued financing activities
Financing cash flow 21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M---3.78M-103.87%-3.39M---2.09M
Net cash flow
Beginning cash position -20.33%68.04M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M3,778.14%85.4M-16.16%72.64M-11.47%76.96M8,471.89%82.23M3,778.14%85.4M
Current changes in cash -2.92%-17.86M-140.04%-11.03M-182.79%-12.22M76.53%-1.24M308.61%6.62M-120.86%-17.35M-269.78%-4.6M-1,346.47%-4.32M-106.12%-5.26M-155.74%-3.17M
Effect of exchange rate changes 92.99%-50891.70%-438141.90%1.07K-120.97%-1.59K-65.41%451-256.67%-7.25K-248.87%-5.28K-1,116.19%-2.55K-124.78%-720180.74%1.3K
End cash Position -26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M-16.16%72.64M-11.47%76.96M8,471.89%82.23M
Free cash flow 43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M12.64%-1.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg